AGP Executive Report
Last update: 10 hours agoSynthetic Food Safety: A peer-reviewed study challenges “synbio milk” claims, finding 93 uncharacterized compounds and 236 fungal proteins in Perfect Day’s product, with critics urging mandatory safety testing as Italy moves to ban synthetic foods. Telehealth Billing Scrutiny: California and the U.S. say Circle Medical submitted claims for services not provided or supervised; the company and its medical director agree to a $3.3M settlement. Diabetes Care Gaps: A new analysis finds racial and ethnic disparities in diabetes screening and annual exam completion, with Hispanic/Latino patients far less likely to complete recommended care. Women’s Intimate Health Innovation: Good Clean Love expands into a telemedicine platform aimed at chronic vaginal health concerns, leaning on microbiome-focused, pH-balanced products. Hospital Preparedness: Hospitals in storm-prone areas are planning for power and water disruptions to keep care running during hurricanes. Oncology Tech & Education: A community oncology playbook highlights regional practice differences, while an India breast-health effort uses AI-enabled holographic lectures to push early detection. Pharma Manufacturing Moves: Alembic wins U.S. tentative approval for generic larotrectinib capsules, and ADCAN Pharma partners with Menarini to localize manufacturing in the UAE.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.